Safety and effectiveness of pediatric growth hormone therapy: Results from the full cohort in KIGS
1University of Genova, Genova, Italy; 2University Children´s Hospital, Tübingen, Germany; 3Childrens Hospital Los Angeles, Los Angeles, USA; 4Aglaia Kyriakou Childrens Hospital, Athens, Greece; 5Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany; 6University of Gothenburg, Gothenburg, Sweden; 7Sant Joan de Déu, Barcelona, Spain; 8Health Institute Carlos III, Madrid, Spain; 9Pfizer, New York, USA; 10Liggins Institute, University of Auckland, Auckland, New Zealand; 11PendoCon, Putte, Belgium; 12Pfizer, Brussels, Belgium; 13AP-HP, Paris, France; 14Polish Mothers Memorial Hospital-Research Institute, Lodz, Poland; 15Medical University of Lodz, Lodz, Poland; 16Université Paris Descartes; Hopital Necker Enfants Malades, Paris, France; 17The Childrens Hospital of Philadelphia, Philadelphia, USA
hrp0094p1-138